February 29, 2024
CellCarta offers a full range of validated human IHC, multiplex IHC (mIHC) and multiplex immunofluorescence (mIF) assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with hundreds more than represented in the brochure.
Contact us for any custom development!
You might also be interested by
Posters
Seeing the Whole Picture: A Comparative Analysis of Digital Pathology Whole Slide Scanners
October 24, 2023
Histopathology
More infoScientific Publications
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
July 18, 2022
Histopathology
More info